[1]
V. Moyseyenko, “PATHOGENETIC FOUNDATION OF LOSARTAN TREATMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH ASYMPTOMATIC HYPERURICEMIA”, Ukr. J. Nephrol. Dial., no. 2(34), pp. 48-52, Dec. 2017.